Navigation Links
Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
Date:7/9/2009

PLYMOUTH, Mass., July 9 /PRNewswire/ -- Harvest Technologies Corp. (www.harvesttech.com) announced today that the company sponsored 60-patient clinical trial conducted at Sri Ramachandra Medical Center in Chennai, India using the company's BMAC System to treat patients with non-reconstructable Critical Limb Ischemia (CLI) has completed enrollment. Sri Ramachandra Medical Center is a Harvard Medical international-associated institution based in Chennai, India and one of the largest private healthcare facilities in South Asia. The study was directed by Prof. K. S. Vijayaragavan, Chief of Vascular Surgery at Sri Ramachandra University and met all regulatory approvals imposed by the Drug Controller of India and the Ethics Committee of Sri Ramachandra University, Chennai, India.

Critical limb ischemia is a persistent and relentless problem, which severely impairs the patient functional status and quality of life, and is associated with an increased cardiovascular mortality and morbidity. Prognosis of critical limb ischemia is poor and no effective treatments have been established in patients who are not amenable for the traditional revascularization therapies such as angioplasty and bypass procedures. Hence these patients have no option other than undergoing amputation or limb loss. In India a significant percentage of these patients with peripheral vascular disease are between the ages of 40 to 50. They suffer from ThromboAngitis Obliterans, which is predominant in young smokers. They have severe pain and limb loss is significant because revascularization chances are very low in these patients. Most of them end up in major amputation, lose their job and become dependant on their family to look after them.

Autologous cell therapy has been studied as an innovative treatment option for CLI, however; previously published studies did not use a rapid, point of care
'/>"/>

SOURCE Harvest Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nanowire generates power by harvesting energy from the environment
2. Fiber-based nanotechnology in clothing could harvest energy from physical movement
3. Carrington and Universal Harvest Sign Supply Agreement
4. BASF Podcast - Better Harvest in Spite of Climate Stress
5. Mach One Corporation Signs Definitive Agreement to Acquire Ceres Organic Harvest, Inc.
6. Mach One Corporation Completes Acquisition of Ceres Organic Harvest, Inc.
7. Scientists determine the structure of highly efficient light-harvesting molecules in green bacteria
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... STOCKHOLM, November 20 Karolins...n Investment Fund (EIF) has entered into a,co-inve...nt fund will be,managed by Karolinska Development ...arly-stage pharmaceutical and medical technology c... the co-investment fund. The agreement,represents ...
(Date:11/19/2009)...AGEN, Nov. 19 Danish Prince Joachi...ic ethanol plant in Kalundborg, Denmark, on Wednes...,s first and largest 2nd generation ethanol demons...mes are used in the plant,s innovative process for... Danisco, was the first to market with commercial ...
(Date:11/19/2009)...SDA, Md., Nov. 19 Spheri...iotechnology for diabetes therapy, and a provider ... food, supplement, biotechnology and pharmaceutica...y,s Annual Meeting of Shareholders. ,, At the m...aq: SPEX ) elected the following members to the B...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies For...o Coordinate Best Practices in Risk Reduction ,F...wide Gene Synthesis Capacity , ...ld’s leading gene synthesis companies today ...screening protocol to promote biosecurity in the g...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...w.thirdbiotech.com ), a biotechnology incubator an...Kemeta, a medical device company,specializing in t...ensing,technology and products, has become ThirdBi...om.com/cgi-bin/prnh/20070911/LATU119LOGO ), "We,v...nization for,bringing together the life sciences i...
...Call/ -- China Yingxia,International, Inc. (OTC Bu...ny"), a leading provider in the nutraceutical indu...istribution of organic nutritional food,products, ...ple,s Republic,of China ("PRC"), announced today i...t 15, 2008, at 9:00 a.m. EDT, to discuss the Compa...
...SM), a developer of follow-on biologics and biopha...d quarter and six-months ended June 30, 2008., R...Program -- Completed clinical trial demonstrat...ny,s recombinant human granulocyte colony stimulat...approved G-CSF product for the treatment of...
Other Biology Technology:ThirdBiotech Announces Kemeta as Newest Sponsor 2China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results 2Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 2Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 3Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 4Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 5Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 6Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 7Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 8Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 9Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008 10
(Date:11/20/2009)...oduction of flax shives, and generated from Brass...those which engulf fields in spring, can be used t...wo studies carried out by Spanish and Dutch resear...Sustainable Energy Reviews . , "These studies eva...oduction of bioethanol from two, as yet unexploite...
(Date:11/20/2009)...Research Center (ERC) has been awarded a grant fro...ethods of recovering and reusing the heat that wou...ression process in a carbon capture system. The go... capture and sequestration, or storage (CCS), and ...emitted into the atmosphere by coal-fired power pl...
(Date:11/19/2009)...brain chemical with an unwieldy name: 4-hydroxybut...used as a date-rape drug. , Now, a team of Ohio...s by which 4-HB is metabolized by the body. "This ... Gibson, professor and chair of biological science...r of the research team. "It may provide new clues...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Public Call for Participation on National Board of Certification for Medical Interpreters 48574 1Public Call for Participation on National Board of Certification for Medical Interpreters 48574 2Public Call for Participation on National Board of Certification for Medical Interpreters 48574 3Mobile Massage Team to Sponsor and Exhibit at First Annual Working Wellness Expo 48572 1Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 1Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 2Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 3Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 4
...ANOVER, NH A group of Dartmouth researchers has f...ed with chromosome segregation during cell divisio...ut the fundamental workings of cells, and contribu...g, as it does with cancerous cells. , The resear...ted to the motor proteins that power diverse cellu...
...A JOLLA, Calif., January 9, 2009 -- Researchers at...am) have shown that search algorithms used in digi...fective multi-drug combinations. The study, led by...in the December 26, 2008, issue of PLoS Computati...ithm, which was developed for digital communicatio...
...OBOKEN, N.J. Citing the importance of proper comm...ens Institute of Technology has received a grant t... undergraduate students. , Through a $25,000 gra...e Writing and Communications at the Institute (WCI...ops to engineering students in their junior and se...
Other Biology News:Dartmouth researchers find new protein function 2Digital communication technology helps clear path to personalized therapies 2Stevens receives $25,000 grant from the Engineering Information Foundation 2
Silencer Pre-designed siRNA, standard purity, annealed from Ambion
Rabbit Anti-Human Q86SZ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Custom siRNA, standard purity from Ambion
Custom siRNA, standard purity from Ambion
Biology Products: